Susquehanna International Group’s SQZ Biotechnologies Company SQZ Stock Holding History

Susquehanna International Group’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-29,231	Closed	-$7.89K	–	13492
2023 Q2	$7.89K	Buy	+29,231	New	+$16.6K	﹤0.01%	11790
2022 Q3	–	Sell	-13,549	Closed	-$43K	–	14490
2022 Q2	$43K	Buy	13,549 +3,520	+35%	+$12.7K	﹤0.01%	12062
2022 Q1	$48K	Buy	+10,029	New	+$63.7K	﹤0.01%	12334

Other funds holding SQZ

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

BSB

Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group's SQZ Position: Q3 2023 in Review

Susquehanna International Group sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 29,231 shares — an estimated $7.89K sold.

Susquehanna International Group first reported a position in SQZ in Q1 2022 and held it in 3 quarters. The position peaked at $48K in Q1 2022. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

Susquehanna International Group reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
Susquehanna International Group sold 29,231 SQZ Biotechnologies Company shares in Q3 2023, an estimated $7.89K.
Susquehanna International Group first reported a position in SQZ Biotechnologies Company in Q1 2022 and held it in 3 quarters.
Susquehanna International Group's SQZ Biotechnologies Company position peaked at $48K in Q1 2022.
5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.